Biote (BTMD) | Stock Overview & Key Data
Biote Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $10.52 on May 23, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Biote
BTMD
|
84.97M Micro-cap | -3.85% | 14.21% | 63.04% | -14.12% | -8.91% | -34.92% | -58.66% | -75.15% | -75.52% | -75.52% | -75.52% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
AirSculpt
AIRS
|
172.13M Micro-cap | 0.99% | 5.83% | 80.78% | 93.16% | 174.59% | 17.58% | -31.93% | -66.33% | -66.33% | -66.33% | -66.33% |
|
Kindly MD
KDLY
|
150.19M Micro-cap | -4.64% | -28.80% | 537.43% | 662.24% | 662.24% | 505.56% | 260.93% | 260.93% | 260.93% | 260.93% | 260.93% |
|
Joint
JYNT
|
126.04M Micro-cap | 12.44% | 12.03% | 8.47% | 5.01% | 4.18% | -16.62% | -33.79% | -87.24% | 248.36% | 41.93% | 41.93% |
Ownership & Short Interest
Calculate Your Biote Investment Returns
Long-Term Investment Performance Analysis
Biote stock price in Apr 2021 was $10.05, A $1,000.00 lump sum investment in Biote made 5 years ago would be worth approximately $223.88 today, representing a negative return of -77.61%. This translates to an annualized return (CAGR) of -25.28%.
5 Years 1 Month Investment Scenario (Apr 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BTMD's 52-week high and low?
- In the last 52 weeks, Biote reached a high of $4.75 (on July 29, 2025) and a low of $1.27 (on March 27, 2026).
- What is the market cap and P/E ratio for BTMD?
- Curious about Biote's size and valuation? Its market capitalization stands at 84.97M. When it comes to valuation, the P/E ratio (trailing twelve months) is 3.08, and the forward P/E (looking ahead) is 4.00.
- Does BTMD pay dividends? If so, what's the yield?
- As for dividends, Biote isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Biote's main competitors or similar companies to consider before investing?
When looking at Biote, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% AirSculpt
AIRS172.13M Healthcare Medical Care Facilities 17.58% -31.93% Kindly MD
KDLY150.19M Healthcare Medical Care Facilities 505.56% 260.93% Joint
JYNT126.04M Healthcare Medical Care Facilities -16.62% -33.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Biote Corp.? (e.g., ROE, Debt/Equity)
- To get a sense of Biote's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -53.66%, the Debt to Equity ratio from the most recent quarter is -2.18, and its Gross Profit Margin stands at 68.03%.
- What is the recent revenue and earnings growth for BTMD?
- Looking at Biote's growth, its revenue over the trailing twelve months (TTM) was $192M. Compared to the same quarter last year (YoY), quarterly revenue grew by -6.90%, and quarterly earnings saw a YoY growth of -47.20%.
- How much of BTMD stock is held by insiders and institutions?
- Wondering who owns Biote stock? Company insiders (like executives and directors) hold about 9.77% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 64.32%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.